Literature DB >> 3405317

Actions of BRL 34915 (Cromakalim) upon convulsive discharges in guinea pig hippocampal slices.

C Alzheimer1, G ten Bruggencate.   

Abstract

The effects of the purported K+ channel opener BRL 34915 upon CNS neurons were examined in guinea pig hippocampal slices. Both the EPSP component and the population spike of field potentials recorded in the CA1 area were reduced in amplitude by BRL 34915 (EC50 about 100 mumol/l). In the same concentration range, BRL 34915 also slowed down the bursting rate of pacemaker neurons in the CA3 region. In order to test a possible anticonvulsant efficacy of the drug, the excitability of hippocampal neurons was increased experimentally by changing the ionic composition of the perfusion medium (omission of Ca2+ or Mg2+, elevation of K+). In all three conditions, epileptiform neuronal activity occurred, which was depressed by BRL 34915. The similarity of the effects of BRL 34915 in normal and convulsive slices indicates that the compound acts upon intrinsic nonsynaptic processes controlling neuronal excitability and cell firing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405317     DOI: 10.1007/bf00169535

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  CORTICAL CELLULAR PHENOMENA IN EXPERIMENTAL EPILEPSY: INTERICTAL MANIFESTATIONS.

Authors:  H MATSUMOTO; C A MARSAN
Journal:  Exp Neurol       Date:  1964-04       Impact factor: 5.330

2.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  Epileptiform activity induced by lowering extracellular [Mg2+] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-D-aspartate.

Authors:  P K Stanton; R S Jones; I Mody; U Heinemann
Journal:  Epilepsy Res       Date:  1987-01       Impact factor: 3.045

4.  Nonsynaptic epileptogenesis in the mammalian hippocampus in vitro. II. Role of extracellular potassium.

Authors:  Y Yaari; A Konnerth; U Heinemann
Journal:  J Neurophysiol       Date:  1986-08       Impact factor: 2.714

5.  Dissociation of actions of BRL 34915 in the rat portal vein.

Authors:  S S Shetty; G B Weiss
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

6.  Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices.

Authors:  I Mody; J D Lambert; U Heinemann
Journal:  J Neurophysiol       Date:  1987-03       Impact factor: 2.714

7.  Analysis of carbamazepine actions in hippocampal slices of the rat.

Authors:  T W Hood; J Siegfried; H L Haas
Journal:  Cell Mol Neurobiol       Date:  1983-09       Impact factor: 5.046

8.  Potassium-induced epileptiform activity in area CA3 varies markedly along the septotemporal axis of the rat hippocampus.

Authors:  A C Bragdon; D M Taylor; W A Wilson
Journal:  Brain Res       Date:  1986-07-16       Impact factor: 3.252

9.  Convulsant actions of 4-aminopyridine on the guinea-pig olfactory cortex slice.

Authors:  M Galvan; P Grafe; G ten Bruggencate
Journal:  Brain Res       Date:  1982-06-03       Impact factor: 3.252

10.  Testing of prototype antiepileptics in hippocampal slices.

Authors:  G M Rose; H R Olpe; H L Haas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

View more
  21 in total

Review 1.  Potassium channel openers. Pharmacological effects and future uses.

Authors:  S Duty; A H Weston
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 2.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

3.  Potassium channel activators decrease endogenous glutamate release from rat cerebellar slices.

Authors:  B G Dickie; J A Davies
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

4.  Actions of cromakalim on outward currents of CA1 neurones in hippocampal slices.

Authors:  G Erdemli; K Krnjević
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

5.  Effects of cromakalim (BRL 34915) on potassium conductances in CA3 neurons of the guinea-pig hippocampus in vitro.

Authors:  C Alzheimer; B Sutor; G ten Bruggencate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Cromakalim (BRL 34915) acts on an inwardly rectifying neuronal K+ conductance, which is similar to that activated by adenosine.

Authors:  C Alzheimer; B Sutor; G ten Bruggencate
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

7.  K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion.

Authors:  H Schmid-Antomarchi; S Amoroso; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 8.  Smooth muscle K+ channel openers; their pharmacology and clinical potential.

Authors:  A H Weston
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

9.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

Authors:  C Heurteaux; I Lauritzen; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres.

Authors:  A Spuler; F Lehmann-Horn; P Grafe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.